Literature DB >> 22225285

Dose calculation software for helical tomotherapy, utilizing patient CT data to calculate an independent three-dimensional dose cube.

Simon J Thomas1, Katie R Eyre, G Samuel J Tudor, Jamie Fairfoul.   

Abstract

PURPOSE: Treatment plans for the TomoTherapy unit are produced with a planning system that is integral to the unit. The authors have produced an independent dose calculation system, to enable plans to be recalculated in three dimensions, using the patient's CT data.
METHODS: Software has been written using MATLAB. The DICOM-RT plan object is used to determine the treatment parameters used, including the treatment sinogram. Each projection of the sinogram is segmented and used to calculate dose at multiple calculation points in a three-dimensional grid using tables of measured beam data. A fast ray-trace algorithm is used to determine effective depth for each projection angle at each calculation point. Calculations were performed on a standard desktop personal computer, with a 2.6 GHz Pentium, running Windows XP.
RESULTS: The time to perform a calculation, for 3375 points averaged 1 min 23 s for prostate plans and 3 min 40 s for head and neck plans. The mean dose within the 50% isodose was calculated and compared with the predictions of the TomoTherapy planning system. When the modified CT (which includes the TomoTherapy couch) was used, the mean difference for ten prostate patients, was -0.4% (range -0.9% to +0.3%). With the original CT (which included the CT couch), the mean difference was -1.0% (range -1.7% to 0.0%). The number of points agreeing with a gamma 3%∕3 mm averaged 99.2% with the modified CT, 96.3% with the original CT. For ten head and neck patients, for the modified and original CT, respectively, the mean difference was +1.1% (range -0.4% to +3.1%) and 1.1% (range -0.4% to +3.0%) with 94.4% and 95.4% passing a gamma 4%∕4 mm. The ability of the program to detect a variety of simulated errors has been tested.
CONCLUSIONS: By using the patient's CT data, the independent dose calculation performs checks that are not performed by a measurement in a cylindrical phantom. This enables it to be used either as an additional check or to replace phantom measurements for some patients. The software has potential to be used in any application where one wishes to model changes to patient conditions.

Entities:  

Mesh:

Year:  2012        PMID: 22225285     DOI: 10.1118/1.3668061

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  10 in total

1.  Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion.

Authors:  J Scaife; K Harrison; M Romanchikova; A Parker; M Sutcliffe; S Bond; S Thomas; S Freeman; R Jena; A Bates; N Burnet
Journal:  Br J Radiol       Date:  2014-08-20       Impact factor: 3.039

2.  Recalculation of dose for each fraction of treatment on TomoTherapy.

Authors:  Simon J Thomas; Marina Romanchikova; Karl Harrison; Michael A Parker; Amy M Bates; Jessica E Scaife; Michael P F Sutcliffe; Neil G Burnet
Journal:  Br J Radiol       Date:  2016-01-05       Impact factor: 3.039

3.  Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer.

Authors:  Jessica E Scaife; Simon J Thomas; Karl Harrison; Marina Romanchikova; Michael P F Sutcliffe; Julia R Forman; Amy M Bates; Raj Jena; M Andrew Parker; Neil G Burnet
Journal:  Br J Radiol       Date:  2015-07-24       Impact factor: 3.039

4.  Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy.

Authors:  L E A Shelley; J E Scaife; M Romanchikova; K Harrison; J R Forman; A M Bates; D J Noble; R Jena; M A Parker; M P F Sutcliffe; S J Thomas; N G Burnet
Journal:  Radiother Oncol       Date:  2017-04-28       Impact factor: 6.280

5.  Automatic contour propagation using deformable image registration to determine delivered dose to spinal cord in head-and-neck cancer radiotherapy.

Authors:  P L Yeap; D J Noble; K Harrison; A M Bates; N G Burnet; R Jena; M Romanchikova; M P F Sutcliffe; S J Thomas; G C Barnett; R J Benson; S J Jefferies; M A Parker
Journal:  Phys Med Biol       Date:  2017-07-12       Impact factor: 3.609

6.  Implementation of TomoEDGE in the independent dose calculator CheckTomo.

Authors:  Mathieu Schopfer; Simon J Thomas; G Samuel J Tudor; Jean Bourhis; François Bochud; Raphaël Moeckli
Journal:  J Appl Clin Med Phys       Date:  2017-03-06       Impact factor: 2.102

7.  Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapy.

Authors:  Leila E A Shelley; Michael P F Sutcliffe; Simon J Thomas; David J Noble; Marina Romanchikova; Karl Harrison; Amy M Bates; Neil G Burnet; Raj Jena
Journal:  Phys Imaging Radiat Oncol       Date:  2020-04

8.  Performance Characteristics of an Independent Dose Verification Program for Helical Tomotherapy.

Authors:  Isaac C F Chang; Jeff Chen; Slav Yartsev
Journal:  J Med Phys       Date:  2017 Jul-Sep

9.  A method for acquiring random range uncertainty probability distributions in proton therapy.

Authors:  S M Holloway; M D Holloway; S J Thomas
Journal:  Phys Med Biol       Date:  2017-12-19       Impact factor: 3.609

10.  Anatomical change during radiotherapy for head and neck cancer, and its effect on delivered dose to the spinal cord.

Authors:  David J Noble; Ping-Lin Yeap; Shannon Y K Seah; Karl Harrison; Leila E A Shelley; Marina Romanchikova; Amy M Bates; Yaolin Zheng; Gillian C Barnett; Richard J Benson; Sarah J Jefferies; Simon J Thomas; Raj Jena; Neil G Burnet
Journal:  Radiother Oncol       Date:  2018-07-23       Impact factor: 6.280

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.